Cargando…

AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells

Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer with high risk of relapse and metastasis. TNBC is a heterogeneous disease comprising different molecular subtypes including those with mesenchymal features. The tyrosine kinase AXL is expressed in mesenchymal cells and plays...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zajac, Olivier, Leclere, Renaud, Nicolas, André, Meseure, Didier, Marchiò, Caterina, Vincent-Salomon, Anne, Roman-Roman, Sergio, Schoumacher, Marie, Dubois, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016818/ https://www.ncbi.nlm.nih.gov/pubmed/31963783 http://dx.doi.org/10.3390/cells9010247

Ejemplares similares

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
por: Vinet, Mathilde, et al.
Publicado: (2019)

Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
por: Schoumacher, Marie, et al.
Publicado: (2017)

Clinical value of R-spondins in triple-negative and metaplastic breast cancers
por: Coussy, F, et al.
Publicado: (2017)

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013)

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
por: Maubant, Sylvie, et al.
Publicado: (2015)

Biopathological Significance of PIWI–piRNA Pathway Deregulation in Invasive Breast Carcinomas
por: Meseure, Didier, et al.
Publicado: (2020)

Targeting AXL and RAGE to prevent geminin overexpression-induced triple-negative breast cancer metastasis
por: Ryan, Daniel, et al.
Publicado: (2019)

MicroPET/CT Imaging of AXL Downregulation by HSP90 Inhibition in Triple-Negative Breast Cancer
por: Wang, Wanqin, et al.
Publicado: (2017)

Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer
por: Zhao, Zhenhui, et al.
Publicado: (2020)

Triple‑negative breast cancer cells that survive ionizing radiation exhibit an Axl‑dependent aggressive radioresistant phenotype
por: Ji, Jianfeng, et al.
Publicado: (2023)

LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers
por: Maubant, Sylvie, et al.
Publicado: (2018)

Axl contributes to efficient migration and invasion of melanoma cells
por: Shao, Hanshuang, et al.
Publicado: (2023)

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
por: Cantini, Laura, et al.
Publicado: (2019)

AXL-associated tumor inflammation as a poor prognostic signature in chemotherapy-treated triple-negative breast cancer patients
por: Bottai, Giulia, et al.
Publicado: (2016)

Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants
por: Pareja, Fresia, et al.
Publicado: (2016)

PD-L1 Expression after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancers Is Associated with Aggressive Residual Disease, Suggesting a Potential for Immunotherapy
por: Grandal, Beatriz, et al.
Publicado: (2021)

PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer
por: Spasojevic, Caroline, et al.
Publicado: (2018)

Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition
por: Kong, Lingyu, et al.
Publicado: (2020)

The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
por: Zapperi, Stefano, et al.
Publicado: (2023)

Giving AXL the axe: targeting AXL in human malignancy
por: Gay, Carl M, et al.
Publicado: (2017)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
por: Uribe, Diana J., et al.
Publicado: (2017)

Upcoming translational challenges for uveal melanoma
por: Nabil, Amirouchene-Angelozzi, et al.
Publicado: (2015)

Upcoming translational challenges for uveal melanoma
por: Amirouchene-Angelozzi, Nabil, et al.
Publicado: (2015)

Classification of triple negative breast cancer by epithelial mesenchymal transition and the tumor immune microenvironment
por: Font-Clos, Francesc, et al.
Publicado: (2022)

An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancer
por: Hajalirezay Yazdi, Shadan, et al.
Publicado: (2018)

lncRNA GSEC Promotes the Progression of Triple Negative Breast Cancer (TNBC) by Targeting the miR-202-5p/AXL Axis
por: Zhang, Jianhua, et al.
Publicado: (2021)

Berberine Impairs the Survival of Triple Negative Breast Cancer Cells: Cellular and Molecular Analyses
por: El Khalki, Lamyae, et al.
Publicado: (2020)

AXL knockdown gene signature reveals a drug repurposing opportunity for a class of antipsychotics to reduce growth and metastasis of triple-negative breast cancer
por: Goyette, Marie-Anne, et al.
Publicado: (2019)

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer
por: Suresh, Samyuktha, et al.
Publicado: (2022)

Anti-Axl antibody treatment reduces the severity of experimental autoimmune encephalomyelitis
por: DuBois, Juwen C., et al.
Publicado: (2020)

Targeting AXL in NSCLC
por: Zaman, Aubhishek, et al.
Publicado: (2021)

Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells
por: Zhang, Yingzi, et al.
Publicado: (2021)

Detection of miRNA regulatory effect on triple negative breast cancer transcriptome
por: Martignetti, Loredana, et al.
Publicado: (2015)

Annurca apple polyphenol extract promotes mesenchymal-to-epithelial transition and inhibits migration in triple-negative breast cancer cells through ROS/JNK signaling
por: Vuoso, Daniela Cristina, et al.
Publicado: (2020)

AXL Inactivation Inhibits Mesothelioma Growth and Migration via Regulation of p53 Expression
por: Song, Wei, et al.
Publicado: (2020)

AXL cooperates with EGFR to mediate neutrophil elastase-induced migration of prostate cancer cells
por: Xiao, Zhiguang, et al.
Publicado: (2021)

Homeostatic activation of aryl hydrocarbon receptor by dietary ligands dampens cutaneous allergic responses by controlling Langerhans cells migration
por: Cros, Adeline, et al.
Publicado: (2023)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

AXL induces epithelial to mesenchymal transition and regulates the function of breast cancer stem cells
por: Asiedu, Michael K., et al.
Publicado: (2013)

Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nuuqb6jbsgmimt0i2tp6k367vq